Ipamorelin Dosage Guide
Complete guide to Ipamorelin dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
100 mcg – 300 mcg
Frequency
2 times per day
Total Daily Dose
200 mcg – 600 mcg
Route
subcutaneous
Cycle Length
8–12 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Typical dosing ranges from 200-300mcg administered 2-3 times daily, often combined with CJC-1295.
Administration Method
Subcutaneous injection. Best results when administered fasted or before sleep. Often stacked with GHRH peptides.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 2.5 mg/ml
Volume to inject: 0.080 ml
Syringe units: 8.0 units — fits 0.3 ml syringe
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with Ipamorelin defaults. Adjust values as needed.
Side Effects to Monitor
Generally well-tolerated. May cause mild headaches, lightheadedness, or increased hunger initially.
Safety Considerations & Risks
Long-term effects on natural GH production not fully characterized. Not approved for human use.